| 000 | 00888 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250513134818.0 | ||
| 264 | 0 | _c19980302 | |
| 008 | 199803s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.316.7127.311 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRawlins, M D | |
| 245 | 0 | 0 |
_aClinical benefit must not be confused with cost benefit. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cJan 1998 |
||
| 300 |
_a310-1 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aDrug Approval |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aUnited Kingdom |
| 700 | 1 | _aBreckenridge, A M | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 316 _gno. 7127 _gp. 310-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.316.7127.311 _zAvailable from publisher's website |
| 999 |
_c9441488 _d9441488 |
||